Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
USA v. Bayer Schering Pharma AG, et al.,
Case Number:
1:10-cv-00669
Court:
Nature of Suit:
Judge:
Firms
-
September 05, 2012
Bayer Beats FCA Suit Over Off-Label Yaz Marketing
A Texas federal judge on Friday tossed a lawsuit alleging Bayer Schering Pharma AG defrauded Medicaid by touting off-label uses for contraceptive drugs Yasmin and Yaz, saying a supposed whistleblower was not the original source of the claims because they were previously reported by Law360 and other news outlets.
-
December 14, 2011
Bayer's Off-Label Yaz Marketing Violated FCA: Watchdog
A pharmaceutical company watchdog accused Bayer Schering Pharma AG of marketing its Yasmin and Yaz contraceptives for unapproved purposes and causing doctors to seek Medicaid reimbursements for off-label prescriptions of those drugs, according to court documents unsealed Monday.